$3.72
0.051.36%
Last update: Nov 4, 8:49 AM
Bicycle Therapeutics PLC
BCYCNASDAQ
The average analyst price target for Bicycle Therapeutics is $20.38, 455.3% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $7 to $60. The latest change came on Jul 30, 2026, when Needham lowered its price target on Bicycle Therapeutics from $15 to $14 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
